Clinical Trial Update: Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating adebrelimab in combination with etoposide capsules as maintenance therapy for extensive-stage small cell lung cancer and is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Etoposide capsules (etoposide)

Snippet

Sponsor: Tang-Du Hospital | Conditions: SCLC,Extensive Stage | Phase 2 | Status: RECRUITING